These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24378745)

  • 1. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.
    Cherkasova MV; Faridi N; Casey KF; O'Driscoll GA; Hechtman L; Joober R; Baker GB; Palmer J; Dagher A; Leyton M; Benkelfat C
    Neuropsychopharmacology; 2014 May; 39(6):1498-507. PubMed ID: 24378745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans.
    Casey KF; Cherkasova MV; Larcher K; Evans AC; Baker GB; Dagher A; Benkelfat C; Leyton M
    J Neurosci; 2013 Sep; 33(38):15285-94. PubMed ID: 24048857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
    Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
    Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P
    Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
    Berman BD; Hallett M; Herscovitch P; Simonyan K
    Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers.
    Booij L; Welfeld K; Leyton M; Dagher A; Boileau I; Sibon I; Baker GB; Diksic M; Soucy JP; Pruessner JC; Cawley-Fiset E; Casey KF; Benkelfat C
    Transl Psychiatry; 2016 Feb; 6(2):e740. PubMed ID: 26905412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder.
    Badgaiyan RD; Sinha S; Sajjad M; Wack DS
    PLoS One; 2015; 10(9):e0137326. PubMed ID: 26422146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
    Adler LA; Dirks B; Deas P; Raychaudhuri A; Dauphin M; Saylor K; Weisler R
    BMC Psychiatry; 2013 Oct; 13():253. PubMed ID: 24106804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
    Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
    J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography.
    Tziortzi AC; Haber SN; Searle GE; Tsoumpas C; Long CJ; Shotbolt P; Douaud G; Jbabdi S; Behrens TE; Rabiner EA; Jenkinson M; Gunn RN
    Cereb Cortex; 2014 May; 24(5):1165-77. PubMed ID: 23283687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
    Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.